This company has been acquired
Sierra Oncology Balance Sheet Health
Financial Health criteria checks 5/6
Key information
1.9%
Debt to equity ratio
US$4.86m
Debt
| Interest coverage ratio | n/a |
| Cash | US$274.02m |
| Equity | US$261.62m |
| Total liabilities | US$18.38m |
| Total assets | US$280.00m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SRRA's short term assets ($278.2M) exceed its short term liabilities ($13.1M).
Long Term Liabilities: SRRA's short term assets ($278.2M) exceed its long term liabilities ($5.3M).
Debt to Equity History and Analysis
Debt Level: SRRA has more cash than its total debt.
Reducing Debt: Insufficient data to determine if SRRA's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SRRA has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: SRRA has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 13.3% each year.